![Two new eye drops for Glaucoma approved in US Two new eye drops for Glaucoma approved in US](https://seriousreaders-public.s3.amazonaws.com/blog_post_image/1077/main_2018-02-15.jpg)
Two new eye drops for Glaucoma approved in US
Thursday 15 February 2018Recent approvals by the US Federal Drug Administration (FDA) have led to the availability in America of two new eye drop therapies for Glaucoma. Rhopressa and Vyzulta both reduce intraocular pressure in patients suffering open-angle glaucoma or ocular hypertension.
Both drugs are part of a new class of treatments which target the trabecular network - the main drain through which fluid leaves the eye. One area for on-going research is how the new drugs work in combination with other prostaglandins, which remains unclear.
Although the drugs are not suitable for all glaucoma sufferers, the approvals will be welcome news for many who would prefer non-surgical options.
Sources:
Reuters:
Aerie's glaucoma drug effectively lowers eye pressure: FDA review.Ophthalmology Times:
New glaucoma therapy offers first drug option in years.European Pharmaceutical Review:
FDA approves Vyzulta for open-angle glaucoma and ocular hypertension.
Comments
Post a comment…
A Serious Blog
News and views from around the world on lighting, eyecare and eye conditions.
Twitter: @seriousreaders
Facebook:facebook.com/seriousreaders
Recent posts
- Living with Glaucoma: National Eye Health Week
- The role of light in painting the sky blue
- Five essential summer eye care tips: How to take care of your eyes this summer
- The history of lighting at Wimbledon: A tale of illumination, innovation, and tradition
- From the Chelsea Flower Show to your home: The power of light in plant growth
Don't miss out on exclusive content and all the latest in light and sight. Subscribe to our email list now!